Hospital/Health System

October 13, 2017

Managing Chronic Pain: A Review of the CDC Guidelines

The CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended for clinicians prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life treatment. 
October 13, 2017

Review of Selected NMEs 2017

Spotlighting new molecular entities that target HIV, hepatitis C, urothelial carcinoma, and chronic lymphocytic leukemia.

September 15, 2017

Gynecologic Cancers: What Every Woman Should Know

Pharmacists have the opportunity to educate women on gynecologic cancers and encourage them to have an open dialogue with their gynecologists about risk factors and screenings.
September 15, 2017

Chemotherapy Agents That Cause Cardiotoxicity

Cardiotoxicity, or medication-induced damage to the heart muscle, is a known adverse effect of many conventional chemotherapeutic agents.
August 18, 2017

The Pharmacist’s Role in Pain Management During Transitions of Care

Pharmacists play an important role in pain management as patients transition from one care setting to another by providing such services as medication reconciliation, inpatient services, drug monitoring and assessment, patient and healthcare provider education, discharge counseling, and postdischarge follow-up and planning.
August 18, 2017

Managing Abdominal Hernias

Pharmacists can provide valuable support in ensuring that hernias are effectively treated and that patients are getting the most out of their particular therapy.
July 19, 2017

Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP

Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.
July 19, 2017

The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness

Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.
May 19, 2017

Hypophosphatasia: A Rare Disorder

Hypophosphatasia is a rare genetic metabolic disorder caused by mutations in the tissue nonspecific alkaline phosphatase gene (ALPL) that lead to defective mineralization of the bones and/or teeth.